NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

He's a genius for pointing out how it might not have helped some of those patients? A total of 19 patients were in the study for 2 weeks of injections. That's it. This trial enrolled patients in late stage advanced disease. These same patients had failed prior therapy, 1-6 prior therapies. They had growing tumors. Immunotherapy is known to increase tumor size. And so it shouldn't come as a surprise that roughly 50% of patients tumor grew (to a total of 1 centimeter) to disqualify them from further treatment. The study was a safety. Had it been an efficacy study, perhaps the "size" growth thing wouldn't have mattered as much. For the company to focus mostly on patients that had 4 vaccine injections is not the wrong thing to do. It's the smart thing to do, as they have more data on those patients. The rest of the data is there for scrutiny. But he should at least acknowledge the facts. Majority of the Patients were in the study for 2-4 weeks. That's it. And the facts are, many of the terminally ill patients are still alive. Period.